Broad genomic profiling was used in only 1 in 4 US patients with newly diagnosed metastatic cancer between 2020 and 2022, a new study reported. Although testing rates increased over this time period, ...

This retrospective study analyzed 376 patients with GBC (339 tissue and 37 plasma cell free DNA [cfDNA] samples) from three Indian institutions (2022-2024) using clinically validated next-generation ...

Therapies backed only by lower-tier evidence no better than unmatched treatment ...

Abbott’s major takeover of Exact Sciences showcases a rising push to leverage cancer tests in precision oncology therapy and R&D.

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced it has received a final Medicare coverage determination for its ...

Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell ...

Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations. Tumor-only sequencing has been adopted by many laboratories to guide precision oncology ...

New QIAseq panels launched for use on next-generation sequencers to boost analysis of over 700 genes for comprehensive genomic profiling in research and clinical applications Advancing key ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Next-generation sequencing (NGS) has transformed solid tumor molecular diagnostics by enabling comprehensive genomic profiling. However, traditional NGS workflows are often labor-intensive and ...